Quantcast

Latest chemotherapy Stories

2014-10-23 12:29:06

CARMEL, Ind., Oct. 23, 2014 /PRNewswire/ -- Sylvia Rosenberg was 27 when she found a lump in her right breast. A biopsy confirmed she had early stage breast cancer. Her doctor recommended a lumpectomy followed by chemotherapy and hormone therapy. Sylvia had watched her aunt battle breast cancer, and she was determined to find a better treatment. Her research confirmed that SonoPhoto Dynamic Therapy (SPDT) combined with hyperthermia had a better success rate than conventional...

2014-10-23 08:37:02

LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 mug/kg, Palonosetron, administered as a singledose, is as effective as ondansetron 0.15 mg/kg given three times a day to a maximum dose of 32mg ~ No safety concerns were raised by the study Helsinn Group, the company focused on building quality cancer care, presented data at the International Society of Paediatric Oncology (SIOP) congress establishing that palonosetron, at a dose 20 mug/kg, is a...

2014-10-22 20:23:18

LONDON, Oct. 22, 2014 /PRNewswire/ -- Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 SummaryGlobalData's clinical trial report, "Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an...

2014-10-16 23:03:38

Lawrence Livermore biomedical researcher Mike Malfatti is working with two researchers at the University of California, Davis, Comprehensive Cancer Center to leverage dramatic advances in biological accelerator mass spectrometry (AMS) to see how cancer patients respond to the chemotherapeutic drug carboplatin. Livermore, California (PRWEB) October 16, 2014 Buoyed by several dramatic advances, Lawrence Livermore National Laboratory scientists think they can tackle biological science in a...

2014-10-14 12:30:20

CINCINNATI, Oct. 14, 2014 /PRNewswire-USNewswire/ -- Doctors at Cincinnati Children's Hospital Medical Center have developed a new technique for treating the eye cancer retinoblastoma to improve the odds for preventing eye loss, blindness or death in children with advanced forms of the disease. Treatments for retinoblastoma have progressed dramatically in recent years, one being a procedure called ophthalmic artery infusion chemotherapy. A tiny catheter is inserted into an artery...

2014-10-14 08:33:18

SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ -- Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the Company. Photo - http://photos.prnewswire.com/prnh/20141013/151744 Logo - http://photos.prnewswire.com/prnh/20141013/151743LOGO The patent, entitled "Photodynamic Therapy for Tumors...

2014-10-13 08:26:31

-- First New Fixed Combination Targeting Two Critical Pathways Involved in CINV -- LUGANO, Switzerland and WOODCLIFF LAKE, N.J., Oct. 13, 2014 /PRNewswire/ -- Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO(®) for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. AKYNZEO is the first approved fixed...

2014-10-07 23:00:40

Canada Cancer and Aging Research Laboratory (CCARL) launched in Lethbridge to provide personalized diagnostic and medical solutions for cancer treatment and to develop diagnostic criteria and therapeutic approaches to combat age-related diseases and aging itself. Lethbridge, AB, Canada (PRWEB) October 07, 2014 Canada Cancer and Aging Research Laboratory (CCARL) today announced the launch of its personalized medicine and research programs in Canada. The company plans to unfold its...

2014-10-06 23:00:15

Scientists say targeting an estrogen receptor in the nuclei of cancer cells may make them more sensitive to chemotherapy, without increasing side effects. (PRWEB) October 07, 2014 Researchers in Italy and Sweden have released a report on a method for boosting the effectiveness of chemotherapy for mesothelioma, without increasing toxicity. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now. Research scientists at the University of Piemonte...

2014-10-02 12:28:35

LONDON, Oct. 2, 2014 /PRNewswire/ -- Chemotherapy Induced Anemia - Pipeline Review, H2 2014 SummaryGlobal Markets Direct's, 'Chemotherapy Induced Anemia - Pipeline Review, H2 2014', provides an overview of the Chemotherapy Induced Anemia's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related